The role of the thymus in the control of autoimmunity

Journal of Autoimmunity

Volumn 9, Issue 2, 1996, Pages 241-246

  Heath, Victoria L ^a   Saoudi, Abdelhadi ^a   Seddon, Benedict P ^a   Moore, Nel C ^b   Fowell, D J ^a,c   Mason, Don W ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Self antigens; Self tolerance; T cell anergy; T cell indifference; Thymus

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN;

ANERGY; ANIMAL EXPERIMENT; AUTOIMMUNITY; CONFERENCE PAPER; DIABETES MELLITUS; ETIOLOGY; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; THYMUS;

EID: 0030001123     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0030     Document Type: Conference Paper

References (32)

1. Kappler J.W., Roehm M., Marrack P. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49: 273-280
2. Ohashi P.S., Oehen S., Buerki K., Pircher H., Ohashi C.T., Odermatt B., Malissen B., Zinkernagel R.M., Hengartner H. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65: 305-317
3. Mueller D.L., Jenkins M.K., Schwartz R.H. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7: 445-480
4. Fowell D., Mason D. 1993. Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential. J. Exp. Med. 177: 627-636
5. Stumbles P.A., Penhale W.J. 1993. IDDM in rats induced by thymectomy and irradiation. Diabetes 42: 571-578
6. Saoudi A., Seddon B., Fowell D., Mason D. 1996. The thymus generates regulatory T cells whose physiological role is to control autoimmunity to tissue specific antigens. (Submitted)
7. low subset. J. Exp. Med. 172: 1701-1708
8. - thymocytes that express L-Selectin mediate both normal T cell function and protection of rats from diabetes upon adoptive transfer. (Submitted)
9. Morahan G., Allison J., Miller J.F.A.P 1989. Tolerance of class I histocompatibility antigens expressed extrathymically Nature 339: 622-624
10. Jolicoeur C., Hanahan D., Smith K. 1994. T-cell tolerance toward a transgenic beta cell antigen and transcription of endogenous pancreatic genes in thymus. Proc. Natl. Acad. Sci. USA 91: 6707-6711
11. + T cells in autoimmunity. Ciba Foundation Symposium 195, p. 172. (In press)
12. Antonia S.J., Geiger T., Miller J., Flavell R.A. 1995. Mechanisms of immune tolerance induction through the thymic expression of a peripheral tissue-specific protein. International Immunology 7: 715-725
13. Daniel D., Gill R.G., Schloot N., Wegmann D. 1995. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25: 1056-1062
14. Muir A., Peck A., Clare-Salzler M., Song Y.H., Cornelius J., Luchetta R., Krischer J., Maclaren N. 1995. Insulin immunization of non-obese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J. Clin. Invest. 95: 628-634
15. Keller R.J., Eisenbarth G.S. 1993. Insulin prophylaxis in individuals at high risk of type 1 diabetes. Lancet 341: 927-928
16. Saoudi A., Seddon B., Heath V., Fowell D., Mason D. 1996. The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T cell subset. Immunol. Rev. 149 (In press)
17. Bennett S.T., Lucassen A.M., Gough S.C.L., Powell E.E., Undlien D.E., Prichard L.E., Merrimen M.E., Kawaguchi Y., Dronsfield M.J., Pociot F., Nerup J., Bouzekri N., Cambon-Thomsen A., Ronningen K.S., Barnett A.H., Bain S.C., Todd J.A. 1995. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nature Genetics 9: 284-292
18. Kennedy G.G., Germain M.S., Rutter W. 1995. The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nature Genetics 9: 293-298
19. Fairchild P.J., Wildgoose R., Atherton E., Webb S., Wraith D.C. 1993. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. International Immunology 5: 1151-1158
20. Zal T., Volkmann A., Stockinger B. 1994. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J. Exp. Med. 180: 2089-2099
21. Elliott J., Altmann D.M. 1995. Dual T cell receptor α chain T cells in autoimmunity. J. Exp. Med. 182: 953-960
22. + T cells is governed by a processing factor that maps to the Class II region of the Major Histocompatibility Locus. J. Exp. Med. 182: 1481-1491
23. Raviola E., Karnovsky M.J. 1972. Evidence for a blood-thymus barrier using electron-opaque tracers. J. Exp. Med. 136: 466-498
24. De-Magistris M.T., Alexander J., Coggeshall M., Altman A., Gaeta F.C., Grey H.M., Sette A. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68: 625-634
25. Hsu B.L., Evavold B.D., Allen P.M. 1995. Modulation of T cell development by an endogenous altered peptide ligand. J. Exp. Med. 181: 805-810
26. Jameson S., Bevan M. 1995. T cell receptor antagonists and partial agonists. Immunity 2: 1-11
27. Hogquist K.A., Jameson S.C., Heath W.R., Howard J.L., Bevan M.J., Carbone F.R. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27
28. Windhagen A., Scholz C., Hollsberg P., Fukaura H., Sette A., Hafler D.A. 1995. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2: 373-380
29. Kehrl J.H., Wakefield L.M., Roberts A.B., Jakowlew S., Alvarez-Mon M., Derynck R., Sporn M.B., Fauci A.S. 1986. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163: 1037-1050
30. Kulkarni A.B., Huh C.G., Becker D., Geiser A., Lyght M., Flanders K.C., Roberts A.B., Sporn M.B., Ward J.M., Karlsson S. 1993. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90: 770-774
31. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D. et al. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693-699
32. Cohen I.R. 1992. The cognitive paradigm and the immunological homunculus. Immunology Today 13: 490-494